Multiomics analysis identifies oxidative phosphorylation as a cancer vulnerability arising from myristoylation inhibition.
Beauchamp E, Gamma JM, Cromwell CR, Moussa EW, Pain R, Kostiuk MA, Acevedo-Morantes C, Iyer A, Yap M, Vincent KM, Postovit LM, Julien O, Hubbard BP, Mackey JR, Berthiaume LG.
Beauchamp E, et al. Among authors: pain r.
J Transl Med. 2024 May 7;22(1):431. doi: 10.1186/s12967-024-05150-6.
J Transl Med. 2024.
PMID: 38715059
Free PMC article.